Yocca Frank
CIK 0001733272
Chief Scientific Officer
Filings
23
Latest May 22, 2026
Issuers covered
1
Showing
23 of 23
Page 1
Track record
8 of 9 open-market trades scored (89% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 75% | +3.9% | +5.5% | +14.5% | -17.3% |
| 90 days | 8 | 88% | +41.8% | +44.2% | +64.9% | -2.8% |
| 180 days | 8 | 100% | +74.4% | +75.9% | +82.1% | +60.9% |
| 365 days | 8 | 100% | +81.2% | +78.3% | +96.2% | +70.8% |
Issuers
Companies where Yocca Frank has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BTAI | Bioxcel Therapeutics, Inc. | 23 | May 22, 2026 |
All filings
23 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|